Skip to main content

Advertisement

Table 1 Clinical data of 17 patients with PTU-induced AAV and 64 patients with primary AAV

From: Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis

  PTU-induced AAV Primary AAV
(n = 17) (n = 64)
Male/female 2/15 32/32
Age (years) 30.8 ± 15.2 60.48 ± 15.14
Scr (μM)   
Mean ± SD 75.62 ± 40.64 339.11 ± 237.71
Range 38-176.9 70-1007
Renal insufficiency at diagnosis 13 (76.4%) 48 (75%)
ESR (mm/1 hour) 46.92 ± 38.86 70.05 ± 40.14
Skin rash 5(29.4%) 7 (10.9%)
Arthralgia 9(52.9%) 15(23.4%)
Muscle pain 6 (35.3%) 10 (15.6%)
Lung 6 (35.3%) 43 (67.2%)
ENT 6 (35.2%) 27(42.2%)
Ophthalmic 2 (11.8%) 14(21.9%)
Gastrointestinal 3(17.6%) 11(17.2%)
Nervous system 1 (5.9%) 10(15.6%)
BVAS   
Mean ± SD 17.1 ± 5.5 20.27 ± 5.18
Range 7-31 13-36
  1. AAV ANCA-associated vasculitis, BVAS Birmingham Vasculitis Activity Scores, ENT ear, nose, and throat, SD standard deviation.